Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 20863217)

1.

Effects of L-Carnitine supplement on plasma coagulation and anticoagulation factors in hemodialysis patients.

Hakeshzadeh F, Tabibi H, Ahmadinejad M, Malakoutian T, Hedayati M.

Ren Fail. 2010;32(9):1109-14. doi: 10.3109/0886022X.2010.510617.

PMID:
20863217
2.

Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients.

Steiber AL, Davis AT, Spry L, Strong J, Buss ML, Ratkiewicz MM, Weatherspoon LJ.

JPEN J Parenter Enteral Nutr. 2006 Jan-Feb;30(1):10-5.

PMID:
16387893
3.

Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.

Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook D, Kopple JD.

Kidney Int. 1990 Nov;38(5):904-11.

PMID:
2266674
4.

L-carnitine consecutively administered to patients on hemodialysis improves beta-cell response.

Vazelov E, Borissova AM, Kirilov G, Assenova B, Tchetirska M, Krivoshiev S.

Int J Artif Organs. 2003 Apr;26(4):304-7.

PMID:
12757029
5.

Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access.

LeSar CJ, Merrick HW, Smith MR.

J Am Coll Surg. 1999 Jul;189(1):73-9; discussion 79-81.

PMID:
10401743
6.

Tissue factor coagulation pathway and blood cells activation state in renal insufficiency.

Mercier E, Branger B, Vecina F, Al-Sabadani B, Berlan J, Dauzat M, Fourcade J, Gris JC.

Hematol J. 2001;2(1):18-25.

PMID:
11920229
7.

L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.

Perna AF, Acanfora F, Satta E, Lombardi C, Capasso R, Ingrosso D, De Santo NG.

J Nephrol. 2007 Jan-Feb;20(1):63-5.

PMID:
17347975
8.

Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients.

Bellinghieri G, Savica V, Mallamace A, Di Stefano C, Consolo F, Spagnoli LG, Villaschi S, Palmieri G, Corsi M, Maccari F.

Am J Clin Nutr. 1983 Oct;38(4):523-31.

PMID:
6624694
9.

The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.

Bavbek N, Akay H, Uz B, Uz E, Turgut F, Kanbay M, Senes M, Akcay A, Duranay M.

Ren Fail. 2010 Jan;32(2):157-61. doi: 10.3109/08860221003592812.

PMID:
20199175
10.

Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.

Semeniuk J, Shalansky KF, Taylor N, Jastrzebski J, Cameron EC.

Clin Nephrol. 2000 Dec;54(6):470-7.

PMID:
11140808
11.

The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.

Kavukçu S, Türkmen M, Salman S, Onvural B, Oktay G, Karaman O, Cevik NT.

Turk J Pediatr. 1998 Jan-Mar;40(1):79-84.

PMID:
9673532
12.
13.

Thrombophilic factors in Stage V chronic kidney disease patients are largely corrected by renal transplantation.

Ghisdal L, Broeders N, Wissing KM, Mena JM, Lemy A, Wijns W, Pradier O, Donckier V, Racapé J, Vereerstraeten P, Abramowicz D.

Nephrol Dial Transplant. 2011 Aug;26(8):2700-5. doi: 10.1093/ndt/gfq791. Epub 2011 Feb 1.

PMID:
21285127
14.

Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.

Vaux EC, Taylor DJ, Altmann P, Rajagopalan B, Graham K, Cooper R, Bonomo Y, Styles P.

Nephron Clin Pract. 2004;97(2):c41-8.

PMID:
15218329
15.

Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.

Evans AM, Faull RJ, Nation RL, Prasad S, Elias T, Reuter SE, Fornasini G.

Kidney Int. 2004 Oct;66(4):1527-34.

PMID:
15458447
16.

Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.

Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M, Nakai S, Miwa M, Morita H, Miwa T, Amano I, Maeda K.

Am J Kidney Dis. 1998 Aug;32(2):258-64.

PMID:
9708610
17.

Effect of dialysate composition on the lipid response to L-carnitine supplementation.

Zilleruelo G, Novak M, Hsia SL, Goldberg R, Abitbol C, Monkus E, Strauss J.

Kidney Int Suppl. 1989 Nov;27:S259-63.

PMID:
2699997
18.

[Plasma l-carnitine in patients with chronic hemodialysis. II. Pharmacokinetics of l-carnitine and its replacement therapy in these patients].

Kudoh Y, Shoji T, Oimatsu H, Kikuchi K, Imura O, Watarai I.

Nihon Jinzo Gakkai Shi. 1984 Feb;26(2):195-202. Japanese. No abstract available.

PMID:
6748336
19.

Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.

Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL.

Clin Pharmacol Ther. 2000 Sep;68(3):238-49.

PMID:
11014405
20.

Effects of L-carnitine on arrhythmias during hemodialysis.

Suzuki Y, Narita M, Yamazaki N.

Jpn Heart J. 1982 May;23(3):349-59.

PMID:
6178854
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk